Almirall (Almirall) EV-to-EBITDA : 16.23 (As of May. 27, 2024)

View and export this data going back to . Start your Free Trial

What is Almirall EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Almirall's enterprise value is $2,204.6 Mil. Almirall's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $135.8 Mil. Therefore, Almirall's EV-to-EBITDA for today is 16.23.

The historical rank and industry rank for Almirall's EV-to-EBITDA or its related term are showing as below:

LBTSF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -253.69 Med: 9.36 Max: 153.79
Current: 16.19

During the past 13 years, the highest EV-to-EBITDA of Almirall was 153.79. The lowest was -253.69. And the median was 9.36.

LBTSF's EV-to-EBITDA is ranked worse than
57.2% of 715 companies
in the Drug Manufacturers industry
Industry Median: 14.42 vs LBTSF: 16.19

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Almirall's stock price is $9.51. Almirall's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.071. Therefore, Almirall's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Almirall EV-to-EBITDA Historical Data

The historical data trend for Almirall's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall EV-to-EBITDA Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

11.14

10.66

17.93

11.43

15.40

Almirall Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															9.22	11.43	13.80	12.19	-

Competitive Comparison of Almirall's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almirall's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Almirall's EV-to-EBITDA falls into.

Almirall EV-to-EBITDA Calculation

Almirall's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	2204.607	/	135.836
	=	16.23

Almirall's current Enterprise Value is $2,204.6 Mil.
Almirall's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $135.8 Mil.

Almirall (OTCPK:LBTSF) EV-to-EBITDA Explanation

Almirall's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	9.51	/	-0.071
	=	At Loss

Almirall's share price for today is $9.51.
Almirall's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.071.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Almirall EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Almirall's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (Almirall) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (OTCPK:LBTSF) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.